Trial Site Detail

 

Drug:
IPI-504
Trial:
Study of IPI-504 in GIST patients following failure of at least imatinib and sunitinib
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Terminated

 

Peter McCallum Cancer Institute

10 St Andrews Place     
East Melbourne , Victoria 3002
Australia

 

Principal Investigator:
Grant McArthur, MD
Contact:
Jill Davison +61 3 9656 1111 pager: 7058 jill.davison@petermac.org
Activation Status of this Site:
Closed
Notes about this Site:
Peter McCallum Cancer Institute Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.